|
|
Overview Hysigen provides an extensive array of shRNA reagents to furnish you with optimal tools for your RNAi experiments. We specialize in packaging all major virus types, including lentivirus, AAV, and adenovirus, across various titer scales, facilitating the delivery of your shRNAs into difficult-to-transfect cells. Key Advancements
Workflow 1. Cell Preparation Cell resuscitation culture, using cells with a fast proliferation rate, cells capable of forming good monoclonal clones, and cells with high transfection efficiency are the key factors for the success of the experiment, and it is recommended to meet the following conditions: - Resuscitated cells should be passaged more than 3 times; - Use cells with good clone formation as much as possible; - Passaging of cells 2 days before transfection; - Change the cell culture medium one day before transfection; - Keep the cells at 50-85% confluence before transfection to maintain the cells in the best proliferation state.
2. shRNA + SSR transfection (or Transduction, Depends on the vector type ) - Cell density is 70-85%. - Mix shRNA plasmid+lipo and add to cells. - After incubation at (37 ºC, 5% CO2) overnight. - Observe the GFP expression rate in cell after 48 hours; the positive rate of the GFP control should be more than 50%. Note: All the media used in the transfection process are antibiotic-free media; otherwise, it will lead to cell death.
3. Transfection and Drug Screening After 48h of transfection, the cells are screened with Puromycin (Puro); Once cell confluence reaches 80%, passage the cells at a 1:2–1:3 ratio and continue drug screening for 1–2 weeks. This completes the construction of the stable transfected cell line. Technical Information RNA Interference (RNAi) is the process of effectively silencing or inhibiting the expression of a target gene, which is achieved by degrading the corresponding mRNA of the target gene using double-stranded RNA (dsRNA).
Stable Knockdown of mAimp1 in RAW264.7 Cell line Using shRNA
• Utilized the VIRUS-Free™ PiggyBac system for stable genomic integration (Fig. 1). • Designed three highly specific shRNAs targeting mAimp1 (Fig. 1) and screened for optimal efficacy. • Knockdown efficiency in stable pool cells was validated via qPCR and Western Blot (Fig. 3). Figure 1. Plasmid map
Figure 2. Schematic of the shRNA knockdown strategy
Figure 3. Validation of mAimp1 Knockdown: mRNA and Protein Analysis
|
IF: 45.5 Chen Y, Chen S, Liu Z, Wang Y, An N, Chen Y, Peng Y, Liu Z, Liu Q, Hu X. Red blood cells undergo lytic programmed cell death involving NLRP3. Cell. 2025 Apr 16:S0092-8674(25)00389-7. | IF: 39.3 Ma B, Ju A, Zhang S, et al. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease[J]. Signal Transduction and Targeted Therapy, 2023, 8(1): 229. | IF: 26.6 Wu W, Pu Y, Gao S, et al. Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy[J]. Nano-Micro Letters, 2022, 14(1): 1-21. | IF: 37.3 Zheng Z, Zeng X, Zhu Y, et al. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182- 5p/CYP1B1 axis[J]. Molecular Cancer, 2024, 23(1): 4. | IF: 18.9 Sun J, Yang F, Wang L, et al. Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration[J]. Bioactive Materials, 2023, 23: 247-260. | IF: 18.9 Wei X, Wang L, Duan C, et al. Cardiac patches made of brown adipose-derived stem cell sheets and conductive electrospun nanofibers restore infarcted heart for ischemic myocardial infarction[J]. Bioactive Materials, 2023, 27: 271-287. | IF: 16 Gao Y, Zhu Y, Wang H, et al. Lipid-mediated phase separation of AGO proteins on the ER controls nascent-peptide ubiquitination[J]. Molecular Cell, 2022, 82(7): 1313-1328. e8. | IF: 15.1 Chen X, Hao Y, Liu Y, et al. NAT10/ac4C/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer[J]. Advanced Science, 2023, 10(32): 2302705. | IF: 12.8 Yang H H, Jiang H L, Tao J H, et al. Mitochondrial citrate accumulation drives alveolar epithelial cell necroptosis in lipopolysaccharide -induced acute lung injury[J]. Experimental & Molecular Medicine, 2022, 54(11): 2077-2091. |